Boston Globe Highlights Foundation’s Investments in CF Research
April 7, 2008
The front page of the Boston Globe’s business section features a story about the CF Foundation today. The story, "Drug Makers turning nonprofits for cash," says the Foundation has “awarded more than $300 million to for-profit companies over the past decade to help develop cutting-edge therapies for the debilitating disease, including $192 million in the Boston area.”
An expanded $37.7 million collaboration between the Foundation and EPIX Pharmaceuticals also is highlighted. | 
